BiotechTube
PharmOptima

PharmOptima

Portage, United States· Est.
pharmoptima.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $8M

Overview

PharmOptima is a US-based, privately held contract research organization (CRO) offering specialized preclinical research services, with a noted focus on ocular pharmacology. Its core capabilities span DMPK/ADME, bioanalytical services (LC-MS/MS, ELISA), biochemistry, custom assay development, and in vivo efficacy models. As part of the GD3 network, it provides clients a pathway from early discovery into clinical trial management, positioning itself as a specialized service provider within the broader drug development outsourcing market.

OncologyOphthalmic DiseasesMetabolic DiseasesFibrotic DiseasesRare DiseasesNeurological Disorders

Technology Platform

Integrated preclinical CRO service platform specializing in DMPK/ADME, bioanalytical LC-MS/MS, custom biochemistry and assay development (ELISA, MSD), and in vivo pharmacology with a niche in ocular disease models.

Funding History

2
Total raised:$8M
Series A$5.5M
Seed$2.5M

Opportunities

The growing trend of pharma and biotech outsourcing R&D, combined with its specialized niche in challenging areas like ocular drug development, presents a significant opportunity.
Its integration into GD3 allows it to offer a seamless path from discovery to clinical trials, increasing client retention and value.

Risk Factors

Key risks include dependence on client R&D budgets, making it vulnerable to industry downturns; intense competition in the CRO sector; and operational risks related to data quality and study execution.
Successful integration with its parent company, GD3, is also not guaranteed.

Competitive Landscape

PharmOptima competes in the fragmented preclinical CRO market against large global players (e.g., Charles River, Labcorp) and many small niche specialists. Its differentiation is based on scientific expertise, particularly in ocular models, and its integrated offering through the GD3 network.

More companies in Digital Health & Biotech SaaS →More companies in United States →